Home » Topics » BioWorld Science

BioWorld Science
RSS

Creative Biomolecules, Stryker extend OP-1 agreement

May 17, 1996

SnET2 enters phase I/II for AMD indication

May 17, 1996

Pharmos, Bausch & Lomb expand Lotemax agreement

May 17, 1996

Dorzolamide approved for marketing in Canada

May 17, 1996

BioChem Therapeutic will codevelop VX-710 in Canada

May 17, 1996

SmithKline Beecham claims hemoregulatory agents

May 17, 1996

Mitsui Toatsu claims antitumor trifluorothymidine derivatives

May 17, 1996

Genentech completes investment in IDEC ahead of schedule

May 17, 1996

Patent coverage obtained for Immune Response's cell therapy for B cell lymphoma

May 17, 1996

U.S. NDA filed for bropirimine

May 17, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...